Proniras' Seed VC Round

Proniras raised a round of funding on September 06, 2017.

Proniras Corporation is a Seattle-based biopharmaceutical company focused on developing tezampanel as a medical countermeasure for nerve agent-induced seizures.…

Articles about Proniras' Seed VC Round: